UK Studies Impact Of $295M Roche Diagnostics Deal
The antitrust watchdog said on Monday that it is investigating a proposed $295 million purchase by Swiss drugmaker Roche of parts of diagnostic company LumiraDx Ltd. as it seeks to assess...To view the full article, register now.
Already a subscriber? Click here to view full article